CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biosynex SA Company Snapshot
Biosynex SA operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other pharmaceutical manufacturers in Europe: Celon Pharma SA of Poland (2017 sales of 107.12 million Polish New Zlotys [US$31.82 million] ), Biodue SpA of Italy (35.72 million Euro [US$44.21 million] ), and Biosearch SA which is based in Spain (25.28 million Euro [US$31.29 million] ).

Sales Analysis. During the year ended December of 2017, sales at Biosynex SA were 30.50 million Euro (US$37.75 million). This is an increase of 12.8% versus 2016, when the company's sales were 27.04 million Euro. This was the fifth consecutive year of sales increases at Biosynex SA (and since 2012, sales have increased a total of 1,890%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biosynex SA
  Stock Performance Chart for Biosynex SA
 
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): 3.50
(Figures in Euro)
1 Week 6.4%   13 Weeks 1.2%  
4 Weeks -6.7%   52 Weeks -21.4%  
 
Biosynex SA Key Data:
  Ticker: ALBIO Country: France
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 30,500,000
(Year Ending Jan 2018).
Employees: 105
  Currency: Euro Market Cap: 28,297,773
  Fiscal Yr Ends: December Shares Outstanding: 8,085,078
  Share Type: Actions Ordinaires Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.